Skip to main content
The logo of BioNTech is pictured at Biontech's research laboratory for individualised vaccines against cancer in Mainz, Germany, July 27, 2023. REUTERS/Wolfgang Rattay">

 

近日,A&O Shearman作为BioNTech的法律顾问,为其收购中国生物医药公司普米斯提供法律服务;高赢国际律师事务所则为普米斯提供法律意见。

BioNTech将以8亿美元预付款收购普米斯100%已发行股本,支付方式主要为现金和部分美国存托股份(ADS);此外,BioNTech将在普米斯达到双方约定的里程碑条件时,额外支付最高1.5亿美元的里程碑付款。

该交易预计于2025年第一季度完成。BioNTech未来将支持普米斯的肿瘤研究计划,并获得普米斯研发的BNT327药物的全球所有权——此前,普米斯拥有该药物在大中华地区的商业化权利,并已在癌症患者身上展开临床试验。

普米斯2018年成立于珠海,未来普米斯珠海将成为BioNTech中国研发中心开展相关R&D研究。

A&O Shearman团队由合伙人Matthew Appleton和Clare O'Brien牵头,中国知识产权业务合伙人葛轶君提供支持。

高赢团队由其纽约/香港合伙人潘文森率领。

A&O Shearman, Goodwin on China’s biotech firm’s $950 mln M&A deal

A&O Shearman has advised German drugmaker BioNTech on its $950 million proposed acquisition of China biotech startup Biotheus, with Goodwin Procter advising the acquiree in the deal.

Under the terms of the agreement, BioNTech will pay 800 million dollars for 100% of the issued share capital, with additional milestone payments of up to 150 million dollars. 

The transaction is expected to close in the first quarter of 2025. BioNTech will support Biotheus’ oncology strategy and gain full global rights to its bispecific antibody candidate BNT327, which has been tested in clinical trials with tumor patients. Biotheus previously held the right to commercialize it in the Greater China market.

Moving forward, Biotheus' Zhuhai facility will serve as BioNTech's China R&D centre.

The A&O Shearman team was led by partners Matthew Appleton, Clare O'Brien, with assistance from China IP partner Jill Ge.

The Goodwin team was led by Wendy Pan, and Mayan Katz.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

天元、君合等牵头赤峰黄金2.82亿港元香港上市(ZH/EN)

3月10日,中国最大的民营黄金生产商赤峰吉隆黄金矿业股份有限公司(赤峰黄金)在香港联交所主板成功上市,募资约28亿港元,成为香港联交所上市的第三只“A+H”黄金股。

彭博社:普衡、威嘉领衔约230亿美元巴拿马运河交易(ZH/EN)

据彭博社消息,由贝莱德牵头的财团计划以 228 亿美元的协议收购香港长江和记实业在巴拿马运河两个重要港口的大部分股份,威嘉律师事务所将为买方提供法律服务,普衡律师事务所为卖方提供法律意见。

两家上海律所领衔宁德时代约50亿美元香港上市(ZH/EN)

中国新能源汽车电池巨头宁德时代正式向香港联交所递交招股书。据路透社消息,宁德时代本次募资额约为50亿美元,有望成为继快手之后,四年来港交所最大上市项目。